Ingenia Therapeutics Inc. (KOSDAQ:950260)
18,000
+650 (3.75%)
At close: Aug 28, 2026
64.23% (1Y)
| Market Cap | 890.00B |
| Revenue (ttm) | n/a |
| Net Income | -26.81B |
| EPS | -1,289.44 |
| Shares Out | 49.44M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,522,322 |
| Open | 17,390 |
| Previous Close | 17,350 |
| Day's Range | 17,390 - 18,890 |
| 52-Week Range | 9,900 - 20,900 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |